Imidazole → 5-[[(1,1-Dimethylethyl)diphenylsilyl]oxy]-2-methylpyridine
Reaktionsgleichung
[OH:1][C:2]1[CH:3]=[CH:4][C:5]([CH3:8])=[N:6][CH:7]=1.N1C=CN=C1.[Si:14](Cl)([C:27]([CH3:30])([CH3:29])[CH3:28])([C:21]1[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=1)[C:15]1[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=1>C(Cl)Cl>[Si:14]([O:1][C:2]1[CH:3]=[CH:4][C:5]([CH3:8])=[N:6][CH:7]=1)([C:27]([CH3:30])([CH3:29])[CH3:28])([C:21]1[CH:22]=[CH:23][CH:24]=[CH:25][CH:26]=1)[C:15]1[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=1Komponenten
5
Edukt 3
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
A solution of 10.9 g 5-hydroxypicoline, 8.85 g imidazole and 29.9 mL of t-butyldiphenylsilylchloride in 500 mL of CH2Cl2 was stirred for 4 days at 25° C. The mixture was washed with H2O, brine, dried over MgSO4 and concentrated under vacuum. The crude product was purified by silica gel chromatography (EtOAc/Hexane 10:90) to afford the pure title compound as an oil.
Aufarbeitung
- washThe mixture was washed with H2O, brine
- dry with materialdried over MgSO4
- concentrationconcentrated under vacuum
- customThe crude product was purified by silica gel chromatography (EtOAc/Hexane 10:90)
Quellen und Nachweise
- ORD-Eintrag
- ord-8c77891e03f94b5898c038b77eb4bf57
- Quelldatensatz
- uspto-grants-1993_04
- Patentnummer
- US05202321
Notizen zur Reaktion
Wird geladen…